Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
Paracetamol
Rowex Ltd
N02BE; N02BE01
Paracetamol
10 milligram(s)/millilitre
Solution for infusion
Product subject to prescription which may not be renewed (A)
Anilides; paracetamol
Not marketed
2012-09-07
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT PARACETAMOL 10 MG/ML SOLUTION FOR INFUSION paracetamol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Paracetamol is and what it is used for 2. What you need to know before you use Paracetamol 3. How to use Paracetamol 4. Possible side effects 5. How to store Paracetamol 6. Contents of the pack and other information 1. WHAT PARACETAMOL IS AND WHAT IT IS USED FOR Paracetamol contains the active substance paracetamol, an analgesic (it relieves pain) and an antipyretic (it lowers fever). This medicine is given by intravenous infusion directly into a vein. It is used for • short-term treatment of moderate pain, especially following surgery • short-term treatment of fever. The 100 ml vial is restricted to adults, adolescents and children weighing more than 33 kg. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE PARACETAMOL DO NOT USE PARACETAMOL • if you are allergic to paracetamol or to any of the other ingredients of this medicine (listed in section 6) • if you are allergic to propacetamol (another analgesic and related to paracetamol) • if you suffer from severe liver disease. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before using Paracetamol • Do not exceed the recommended dose. Doses higher than those recommended entail the risk of very serious liver damage. Symptoms of liver damage are not usually seen until 2 days, and up to a maximum of 4-6 days, after administration. • Take care not to exceed the maximum Leggi il documento completo
Health Products Regulatory Authority 13 November 2019 CRN009C4M Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol 10 mg/ml solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml solution for infusion contains 10 mg of paracetamol. Each 100 ml vial contains 1000 mg of paracetamol. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Clear colorless to slightly yellowish, particle-free solution. pH: 5.5 Osmolarity: 295 mOsm/L 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Short-term treatment of moderate pain, especially following surgery, Short-term treatment of fever, when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Intravenous use. The 100 ml vial is restricted to adults, adolescents and children weighing more than 33 kg. Posology Dosing based on patient weight (please see the dosing table here below) PATIENT WEIGHT DOSE PER ADMINISTRATION VOLUME PER ADMINISTRATION MAXIMUM VOLUME OF PARACETAMOL (10 MG/ML) PER ADMINISTRATION BASED ON UPPER WEIGHT LIMITS OF GROUP (ML)** MAXIMUM DAILY DOSE * > 33 KG TO ≤ 50 KG 15 mg/kg 1.5 ml/kg 75 ml 60 mg/kg not exceeding 3 g > 50 KG WITH ADDITIONAL RISK FACTORS FOR HEPATOTOXICITY 1 g 100 ml 100 ml 3 g > 50 KG AND NO ADDITIONAL RISK FACTORS FOR HEPATOTOXICITY 1 g 100 ml 100 ml 4 g Health Products Regulatory Authority 13 November 2019 CRN009C4M Page 2 of 7 *MAXIMUM DAILY DOSE: The maximum daily dose as presented in the table above is for patients that are not receiving other paracetamol containing products and should be adjusted accordingly taking such products into account. **PATIENTS WEIGHING LESS WILL REQUIRE SMALLER VOLUMES. THE MINIMUM INTERVAL BETWEEN EACH ADMINISTRATION MUST BE AT LEAST 4 HOURS. NO MORE THAN 4 DOSES TO BE GIVEN IN 24 HOURS. THE MINIMUM INTERVAL BETWEEN EACH ADMINISTRATION IN PATIE Leggi il documento completo